Boston Scientific down after comments on DOJ
NEW YORK (Reuters) - Shares of Boston Scientific (BSX.N: Quote, Profile, Research) fell 3.1 percent to $7.80 in premarket trading on Friday, after the company reached an agreement with the U.S. Department of Justice related to product recalls issued by its Guidant subsidiary.
The company also said it would record a third-quarter charge of $294 million.
(Reporting by Ryan Vlastelica; Editing by James Dalgleish)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
Back from the Dead
REUTERS WITNESS - 26/11
Reuters correspondent Sourav Mishra recounts the night of Nov. 26 at Leopold Cafe. Full Article | Full Coverage
